Skip to main content
. 2014 May 8;8(5):e2842. doi: 10.1371/journal.pntd.0002842

Table 1. Half maximal effective concentration (EC50) of raloxifene against Leishmania spp.

Leishmania species Stagea Condition (medium or buffer) Time of incubation (hours) EC50 ± SDb
L. amazonensis P M199 24 30.2±1.7
L. amazonensis P M199 2 30.6±1.0
L. amazonensis P HBSS+Glc 2 9.3±1.0
L. braziliensis P M199 24 38.0±8.4
L. donovani P M199 24 32.5±1.3
L. infantum chagasi P M199 24 30.9±0.5
L. major P M199 24 32.6±1.4
L. mexicana P M199 24 30.3±1.3
L. amazonensis LA RPMI 24 15.0±2.3
L. amazonensis IA RPMI 48 16.2±2.2
L. infantum chagasi IA RPMI 48 8.8±1.1
a

Parasite form: P: promastigotes; LA: lesion derived amastigotes; IA: intracelullar amastigotes. Half maximal effective concentration against promastigotes and axenic lesion-derived amastigotes was determined through MTT or MTS as described [20]; activity against L. amazonensis and L. infantum chagasi intracellular amastigotes was determined through luciferase activity or microscopic counting, respectively, as described in Material and Methods.

b

The results are expressed as the mean and standard deviation (± SD) of three independent experiments, each one performed in triplicate.